McIlrath & Eck’s iShares iBonds Dec 2025 Term Corporate ETF IBDQ Stock Holding History

McIlrath & Eck’s Portfolio IBDQ Stock Details IBDQ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2,432	Closed	-$61.3K	–	998
2025 Q3	$61.3K	Buy	2,432 +25	+1%	+$628	0.01%	282
2025 Q2	$60.6K	Buy	+2,407	New	+$60.5K	0.01%	282

Other funds holding IBDQ

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Mercer Global Advisors Denver, Colorado $67.6B AUM 18.3% 1-Year Est. Return

Balentine LLC Atlanta, Georgia $2.48B AUM 17.44% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

McIlrath & Eck's IBDQ Position: Q4 2025 in Review

McIlrath & Eck sold out of iShares iBonds Dec 2025 Term Corporate ETF (IBDQ) in Q4 2025, closing a stake of 2,432 shares — an estimated $61.3K sold.

McIlrath & Eck first reported a position in IBDQ in Q2 2025 and held it in 2 quarters. The position peaked at $61.3K in Q3 2025. 3 funds tracked by Wall St. Rank hold IBDQ as of Q4 2025.

McIlrath & Eck reported no remaining iShares iBonds Dec 2025 Term Corporate ETF position as of Q4 2025 after selling out during the quarter.
McIlrath & Eck sold 2,432 iShares iBonds Dec 2025 Term Corporate ETF shares in Q4 2025, an estimated $61.3K.
McIlrath & Eck first reported a position in iShares iBonds Dec 2025 Term Corporate ETF in Q2 2025 and held it in 2 quarters.
McIlrath & Eck's iShares iBonds Dec 2025 Term Corporate ETF position peaked at $61.3K in Q3 2025.
3 funds tracked by Wall St. Rank held iShares iBonds Dec 2025 Term Corporate ETF as of Q4 2025.

Based on McIlrath & Eck's 13F filing for Q4 2025, filed 3 Feb 2026.